HomeBIIB • NASDAQ
add
Biogen Inc
$139.31
Makalipas ang Oras ng Trabaho:(0.17%)+0.23
$139.54
Sarado: Ago 22, 6:11:31 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$139.12
Sakop ng araw
$138.65 - $142.32
Sakop ng taon
$110.04 - $206.70
Market cap
20.42B USD
Average na Volume
1.44M
P/E ratio
13.32
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.65B | 7.33% |
Gastos sa pagpapatakbo | 1.18B | 2.07% |
Net na kita | 634.80M | 8.77% |
Net profit margin | 24.00 | 1.35% |
Kita sa bawat share | 5.47 | 3.60% |
EBITDA | 1.11B | 14.61% |
Aktuwal na % ng binabayarang buwis | 14.68% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.76B | 44.52% |
Kabuuang asset | 28.33B | 5.69% |
Kabuuang sagutin | 10.70B | -2.00% |
Kabuuang equity | 17.63B | — |
Natitirang share | 146.61M | — |
Presyo para makapag-book | 1.16 | — |
Return on assets | 8.12% | — |
Return on capital | 9.57% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 634.80M | 8.77% |
Cash mula sa mga operasyon | 160.90M | -74.29% |
Cash mula sa pag-invest | -57.00M | -112.22% |
Cash mula sa financing | -11.70M | 95.23% |
Net change in cash | 160.50M | -80.77% |
Malayang cash flow | 223.68M | -83.73% |
Tungkol
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland. Wikipedia
Itinatag
1978
Headquarters
Website
Mga Empleyado
7,605
